Get started
Author

Xiaoli Zhu

Observed names: X L Zhu, X. Zhu, Xiao-Li Zhu, Xiao-li Zhu, Xiao‐Li Zhu, Zhu, Xiaoli
Observed institutions: Cleveland Clinic, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Soochow University, Peking University Cancer Hospital, Fifth Affiliated Hospital of Sun Yat-sen University, Yancheng Third People's Hospital, First Affiliated Hospital of Soochow University, Guangzhou Medical University Cancer Hospital, Guizhou Provincial People's Hospital, First Affiliated Hospital Zhejiang University, Suzhou University, Fujian Police College, Zhejiang University, Guangzhou Medical University, Air Force Medical University
ORCID: 0000-0003-0998-0124
Observed ORCID: 0000-0003-0998-0124
OpenAlex ID: A5101928521
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
2024 · Zhi-Cheng Jin, Jian-Jian Chen, et al. · EClinicalMedicine · 193
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study
2023 · Zhi-Cheng Jin, Bin-Yan Zhong, et al. · European Radiology · 107
PDF
Utility of the Amplatzer Vascular Plug in Splenic Artery Embolization: A Comparison Study with Conventional Coil Technique
2010 · Xiaoli Zhu, Matthew D. B. S. Tam, et al. · CardioVascular and Interventional Radiology · 69
Retrievability and Device-Related Complications of the G2 Filter: A Retrospective Study of 139 Filter Retrievals
2011 · Xiaoli Zhu, Matthew D.B.S. Tam, et al. · Journal of Vascular and Interventional Radiology · 61
Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response
2022 · Fei Yang, Gui-Li Xu, et al. · Frontiers in Immunology · 53
PDF
Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib
2020 · Lei Zhang, Wei Xia, et al. · Frontiers in Oncology · 48
PDF
Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium‐Enhanced MRI
2022 · Fang‐Ming Chen, Mingzhan Du, et al. · Journal of Magnetic Resonance Imaging · 43
Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembolization monotherapy: A multicenter study
2021 · Zhicheng Jin, Li Chen, et al. · Translational Oncology · 42
PDF
Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
2022 · Jin-Tao Huang, Bin-Yan Zhong, et al. · Journal of Hepatocellular Carcinoma · 33
PDF
High Epithelial Cell Adhesion Molecule–Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization
2018 · Jian Shen, Wan-Sheng Wang, et al. · Journal of Vascular and Interventional Radiology · 32
Prognostic Performance of Albumin–Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
2020 · Bin-Yan Zhong, Zhi-Ping Yan, et al. · Frontiers in Oncology · 24
PDF
Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
2018 · Kai Wang, Guomin Jiang, et al. · Medicine · 23
Transarterial chemoembolization combined with molecularly targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a retrospective cohort study
2023 · Nan Jiang, Binyan Zhong, et al. · Frontiers in Immunology · 21
PDF
Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in a Chinese population
2010 · H W Xiao, X Y Lai, et al. · Bone Marrow Transplantation · 19
Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization
2023 · Bin-Yan Zhong, Jian-Qiang Jiang, et al. · Journal of Clinical and Translational Hepatology · 18
PDF
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆
2024 · Dongdong Xia, Wei Bai, et al. · JHEP Reports · 17
PDF
Identifying the factors affecting financial toxicity status in patients with middle and advanced colorectal cancer: a cross-sectional study
2024 · Xiaofang He, Jie Chen, et al. · Frontiers in Public Health · 16
The Added Value of Sarcopenia on Existing Risk Scores to Predict Mortality after TIPS Placement: A Multicenter Study
2023 · Bin Xiong, Chongtu Yang, et al. · Academic Radiology · 16
Multiparametric MRI-based Machine Learning Radiomics for Predicting Treatment Response to Transarterial Chemoembolization Combined with Targeted and Immunotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Study
2024 · Wendi Kang, Peiyun Tang, et al. · Academic Radiology · 14
Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy
2023 · Ze-Xin Hu, Xiao-Yang Xu, et al. · Journal of Hepatocellular Carcinoma · 13
PDF
CircFMN2 Boosts Sorafenib Resistance in Hepatocellular Carcinoma Cells via Upregulating CNBP by Restraining Ubiquitination
2022 · Chen Fan, Xiaoli Zhu, et al. · Journal of Oncology · 12
PDF
In vivo evaluation of callispheres microspheres in the porcine renal artery embolization model.
2019 · Baosheng Ren, Wansheng Wang, et al. · PubMed · 11
Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
2023 · Jian-Qiang Jiang, Jin-Tao Huang, et al. · Journal of Hepatocellular Carcinoma · 10
PDF
Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR‐34a‐5p/PD‐L1 axis
2023 · Tingting He, Jintao Huang, et al. · Cell Biology International · 10
PDF
Treatment strategies and indications for interventional management of pseudoaneurysms.
2011 · Xiao-Li Zhu, Cai-Fang Ni, et al. · PubMed · 10
Works count: 62
Citation count: 1,005
H-index: 16
I10-index: 25
Year
Topic
Type